Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised

Xiao-Ping Cui1, Min Lin1, Jun-Shan Mu1

  • 1Department of Neurology, Fuzhou General Hospital of Nanjing Command, People's Liberation Army and Clinical Medical College of Fujian Medical University, Fuzhou, China.

BMJ Open
|November 18, 2016
PubMed

Insights

This study investigates if percutaneous transluminal angioplasty and stenting (PTAS) improves outcomes for symptomatic intracranial atherosclerosis (ICAS). The randomized trial compares PTAS plus medical treatment versus medical treatment alone to assess stroke and death incidence.

Area of Science:

  • Neurology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Symptomatic intracranial atherosclerosis (ICAS) poses a significant risk of stroke.
  • The efficacy of percutaneous transluminal angioplasty and stenting (PTAS) as an adjunct to medical treatment for ICAS remains debated.
  • There is a need to evaluate improved PTAS procedures for managing ICAS.

Purpose of the Study:

  • To determine the effectiveness and safety of an improved PTAS procedure combined with medical treatment (MT) for patients with symptomatic ICAS.
  • To compare the incidence of stroke or death in patients receiving MT plus PTAS versus MT alone.
  • To assess secondary outcomes including ischemic stroke, restenosis, and quality of life.

Main Methods:

  • A randomized controlled trial conducted in three Chinese hospitals.
  • Eligible patients with ICAS were randomized to receive MT plus PTAS or MT alone.
  • Primary endpoint: incidence of stroke or death at 30 days. Secondary endpoints: ischemic stroke, in-stent restenosis, modified Rankin Scale, and CSQoL.

Main Results:

  • Data on the main results are not yet available as this describes a study protocol.
  • The study is registered under NCT02689037.
  • Follow-up is planned at 30 days, 3 months, and 12 months post-randomization.

Conclusions:

  • The study aims to provide evidence to guide clinical decision-making for ICAS management.
  • Findings are expected to inform improvements in current PTAS procedures.
  • Dissemination of results will occur through peer-reviewed publications and conference presentations.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
425
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
540
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374